QualityStocksNewsBreaks Archives - Page 860 of 1423

ThursdayOct 01, 2020 10:38 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Achieves Critical Milestone for Production of Lead Drug Candidate

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that its GMP manufacturer partner NCK A/S, received a Certificate of Analysis (“CoA”) for its Active Pharma Ingredient (“API”), clearing it for use in the production of Berubicin. CNS Pharmaceuticals previously announced entry into a contract with NCK A/S, a GMP manufacturer of complex drugs and the previous producer of Berubicin for Reata Pharmaceuticals, for the large-scale production of Berubicin, CNSP’s lead drug candidate for the treatment of glioma brain tumors. "We…

ThursdayOct 01, 2020 10:30 am

QualityStocksNewsBreaks – Sanwire Corp. (SNWR) Subsidiary Distribution Now Includes Amazon International, Barnes & Noble, Target.com

Sanwire (OTC: SNWR), a diversified company with a focus on technologies for the entertainment industry, announced that, through its subsidiary Intercept Music Inc., it has expanded its distribution network to include additional major retailers. Earlier this Intercept launched its physical distribution network with numerous retail giants, including Amazon.com, Walmart.com and FYE. That distribution list has since grown as the company has added Amazon International, Target.com, Barnes & Noble, BarnesAndNoble.com and Tower Japan; these major retailers have become available through distribution partner Super D. Intercept’s distribution platform also includes a physical distribution network of more than 1,000 U.S. and global record stores.…

ThursdayOct 01, 2020 10:24 am

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) Receives Import Licenses, Announces Planned Shipment Date

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified-organic cannabis, has received import licenses from Australia and Germany and is on track to commence commercialization in both countries next year. Receiving these licenses means that TGOD is approved to export its premium certified organically grown products. The company’s strategic plan for next year includes the export of its first commercial shipment. In preparation for that, the company has submitted an application to Health Canada for export licenses. TGOD already has a distribution agreement in place with LeafCann, which is located in Australia. Its wholly owned subsidiary…

ThursdayOct 01, 2020 9:55 am

QualityStocksNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) CEO Discusses ‘Sea of Change’ to Future of Anxiety Treatment

VistaGen Therapeutics’ (NASDAQ: VTGN) CEO Shawn Singh authored a recent article for Life Science Leader titled, “The Future of Anxiety Treatment Will Be Drastically Different.” In the piece, Singh, an experienced professional who has dedicated over 25 years to biopharma and medical device industries, addresses the current standard of care for anxiety disorders and its inability to meet the growing need. “As researchers learn more about psychological therapy for anxiety disorders and medication options to complement it, efforts are underway to develop innovative medications to displace current anti-anxiety drugs that are not effective for all patients and are associated with…

WednesdaySep 30, 2020 1:53 pm

QualityStocksNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Enters Updated LOI to Acquire 51% of Mobile Game Developer Csfctech

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality ("AR") interactive entertainment games, toys and educational materials in China, today announced its entry into an updated letter of intent (“LOI”). Under the terms of the LOI, BHAT will acquire the control of 51% of Fuzhou Csfctech Co. Ltd. ("Csfctech") and its two subsidiaries through the direct acquisition of 51% of the outstanding shares of its offshore holding company. Csfctech is a developer and distributor of mobile games with an international user base across Mainland China, Japan, Taiwan, the United Arab Emirates and Africa.…

WednesdaySep 30, 2020 10:24 am

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Signs Agreement for Property to Use for Planned Cannabis Cultivation

Sugarmade (SGMD) a leading, multidivisional/multiproduct/multisector supply company, has entered into a property lease agreement with LMK Capital LLC. The agreement includes five acres of cropland located in Northern California, which has been zoned for cannabis cultivation. Sugarmade plans to use the property to operate a licensed cannabis production business, which it anticipates may produce up to 3.6 million grams of high-quality cannabis flower annually. The company’s strategic plan calls for marketing the cannabis as both white-label and branded cannabis products through various distributors. Among those distributors will be BudCars Cannabis Delivery Service (“BudCars”), a cannabis delivery company that is seeing…

WednesdaySep 30, 2020 10:15 am

QualityStocksNewsBreaks – Creatd Inc. (NASDAQ: CRTD) Appoints New COO to Lead Growth Strategy, Manage Partnership Initiatives

Creatd (NASDAQ: CRTD, CRTDW), the parent company and creator of the Vocal platform, today announced the appointment of Laurie Weisberg as its new chief operating officer. Weisberg currently sits on Creatd’s board of directors and will lead the company's sales team in the execution of its growth strategy and manage all strategic partnership initiatives. This appointment aligns with Creatd's 2021 plans to broaden and scale its product line and revenues, including Vocal for Brands, Seller's Choice, and Vocal+ paid subscriptions. "I have closely observed the Creatd team over the last year, particularly since I assumed my role as a member…

WednesdaySep 30, 2020 9:55 am

QualityStocksNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Closes Upsized NASDAQ Initial Public Offering

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) (NASDAQ: SYTA, SYTAW), a leading global developer and provider of Push-to-Talk Over Cellular (“PTT/PoC”) systems for enterprise customers, has announced the closing of its upsized $12.6 million U.S. initial public offering on the NASDAQ. The company had previously announced the IPO of 2,100,000 units at a price of $6 per unit, with each unit comprised of one common share in the capital of the company and one warrant to purchase one common share in the capital of the company. The shares and warrants were issued separately and were approved to list on the Nasdaq…

WednesdaySep 30, 2020 9:35 am

QualityStocksNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) CEO Addresses ‘Multi-Pronged Approach’ to Growing Problem of Workplace Stress and Anxiety

VistaGen Therapeutics’ (NASDAQ: VTGN) CEO Shawn Singh authored a recent article for Business.com regarding the COVID-19 pandemic and resulting stress and anxiety impacts to the workplace. In the piece, Singh indicates that stress and anxiety, often driven by job-related issues, when left unchecked can rise to the level of an anxiety disorder with negative consequences for physical health, mental well-being, productivity and career opportunities. The global pandemic has exacerbated this largely unaddressed and widespread mental health problem in the workplace, markedly reflecting in increased prescriptions for antidepressant and anti-anxiety medications, many associated with significant side effects and safety concerns. “To…

TuesdaySep 29, 2020 2:52 pm

QualityStocksNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) CEO Discusses PH94B Drug Candidate in Applied Clinical Trials Publication

VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, was recently featured in an Applied Clinical Trials article titled, “Pushing Late-Stage Treatments Forward in the Clinic.” In the article, VistaGen’s CEO Shawn Singh discussed the company's ongoing efforts to treat and help manage the anxiety symptoms provoked by COVID-19 and other triggers, anxiety-related disorders initially in subjects suffering from Social Anxiety Disorder (“SAD”), as well as the FDA’s consensus on the design of the company’s pivotal Phase III study of PH94B. The piece quotes Singh, who states, “Now…

Site Search

Company Search

Category: QualityStocksNewsBreaks